Fundamental Data for CBM

Cambrex Corporation manufactures and markets a broad line of specialty chemicals and commodity chemical intermediates and also manufactures chemicals to customer specifications. There are five product categories: pharmaceutical bulk actives; pharmaceutical intermediates; organic intermediates; performance enhancers; and polymer systems.

# Employees: 856

Address: One Meadowlands Plaza,East Rutherford,NJ,USA

Phone: 201-804-3000

Fax: 201-804-9852

Website: www.cambrex.com

Email: ir.cambrex.com

Sector: Basic Materials

Industry: CHEM-DIVERSIFD

Executive Officers

James A. Mack (Chmn.; Presi.; C.E.O.)

Peter E. Thauer (Sr. V.P.; Law & Environment; Gen. Counsl.; Corp. S)

Gregory P. Sargen (V.P.; C.F.O.)

Steven M. Klosk (Exec. V.P.; C.O.O.)

Paolo Russolo (Presi.; Profarmaco Milano,)

Dividend

Ex-Dividend Date: N/A

Annual Dividend: N/A

Current Dividend Yield: N/A

Dividend Paid (3 months): N/A

Indicated Dividend: N/A

Earnings

Last Earnings Date: 9/30/2009

Next Earnings Date(Expected): 2/10/2010

Mean EPS (Next Qtr): $0.06

Mean EPS (Year): $0.49

Mean Estimate(Long Term): $17.00

P/E Ratio(Based on EPS estimate): 11.550

Number of Estimates: 3

Shares Performance

Period	CBM	Compare to S&P
YTD	23.38 %	2.10 %
4 Weeks	-5.00 %	-9.81 %
12 Weeks	-0.35 %	-7.21 %

Shares Information

Analyst Coverage: Y

Avg Volume: 107060

Shares Outstanding: 29M

Market Cap: $0.17B

52 Week High: $7.17

52 Week Low: $1.50

P/E Ratio: 11.400

PEG Ratio: 0.680

Split: On 6/25/1998 CBM split by factor of 2.000

Earnings Performance

EPS Growth in Last Quarter: -47.37 %

EPS Growth in Last Year: 0.00 %

Sales Growth in Last Quarter: -4.91 %

Sales Growth in Last Quarter: -3.30 %

Financials

Qtr Book Value: $1.58

Cash Flow/Share: $5.15

Change in Payout Ratio: -0.390

Price/Sales: 0.690